Cancer Treatment
Findings from the United States, Japan and Germany describe new data in cancer treatment research
Published in Vaccine Weekly, July 12th, 2006
Study 1: MHC class II T helper epitopes for WT1 tumor antigen may aid vaccine development.
According to researchers in Japan and the United States, "The product of Wilms' tumor gene 1 (WT1) is overexpressed in diverse human tumors, including leukemia, lung, and breast cancer, and is often recognized by antibodies in the sera of patients with leukemia. Since WT1 encodes MHC class I-restricted peptides recognized by cytotoxic T lymphocytes (CTL), WT1 has been considered as a promising tumor-associated antigen (TAA) for developing anticancer immunotherapy....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-07-12)
More Articles from Vaccine Weekly
- Herpes Vaccine
CpG oligodeoxynucleotide is potent adjuvant for vaccination against genital herpes - Influenza Vaccine
Inactivated influenza vaccine prevents otitis media in children - Monkeypox Vaccine
Highly attenuated vaccinia virus vaccine protects monkeys against monkeypox - Pertussis Vaccine
Bordetella pertussis filamentous hemagglutinin is vaccine candidate - Streptococcal Vaccine
Tetra-epitopic peptide vaccine protects against group A streptococcus - Alzheimer Disease
A-beta42 gene vaccine reduces brain amyloid plaque burden in mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
